Connection

Hugo Ten Cate to Platelet Activation

Back to Details
This is a "connection" page, showing publications Hugo Ten Cate has written about Platelet Activation.
Hugo Ten Cate
Connection Strength
0.649
Platelet Activation
  1. Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients. Arterioscler Thromb Vasc Biol. 2018 04; 38(4):726-732.
    View in: PubMed
    Score: 0.521
  2. Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy. Haematologica. 2018 09; 103(9):1557-1567.
    View in: PubMed
    Score: 0.033
  3. Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction. Blood Adv. 2018 03 27; 2(6):715-730.
    View in: PubMed
    Score: 0.033
  4. Platelet populations and priming in hematological diseases. Blood Rev. 2017 11; 31(6):389-399.
    View in: PubMed
    Score: 0.031
  5. Platelet full length TFPI-a in healthy volunteers is not affected by sex or hormonal use. PLoS One. 2017; 12(2):e0168273.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.